Terug
Dagbereik
€ 3,04
€ 3,20
52-Weeksbereik
€ 1,67
€ 4,11
Volume
1.278.908
50D / 200D Gem.
€ 3,42
/
€ 3,02
Vorige Slotkoers
€ 3,08
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -6,5 | 0,3 |
| P/B | 4,0 | 3,0 |
| ROE % | -48,6 | 3,7 |
| Net Margin % | -70,4 | 3,8 |
| Rev Growth 5Y % | -30,6 | 10,0 |
| D/E | 0,2 | 0,2 |
Koersdoel Analisten
Hold
€ 4,50
+44.7%
Forward WPA
-€ 0,18
Omzet Sch.
204,75M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
-€ 0,15
-€ 0,15 – -€ 0,15
|
262,65M | 1 |
| FY2029 |
-€ 0,17
-€ 0,17 – -€ 0,16
|
247,15M | 1 |
| FY2028 |
-€ 0,12
-€ 0,15 – -€ 0,10
|
235,92M | 2 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-25 | -€ 0,07 | -€ 0,04 | +43,1% |
| 2025-11-06 | -€ 0,06 | -€ 0,08 | -33,3% |
| 2025-08-11 | -€ 0,06 | -€ 0,08 | -33,3% |
| 2025-05-12 | -€ 0,07 | -€ 0,08 | -14,3% |
| 2025-03-18 | -€ 0,03 | -€ 0,06 | -100,0% |
| 2024-11-07 | -€ 0,01 | -€ 0,02 | -150,0% |
| 2024-08-07 | -€ 0,04 | -€ 0,08 | -100,0% |
| 2024-05-08 | -€ 0,02 | -€ 0,02 | -21,4% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue declined -30,57% annually over 5 years
Debt/Equity of 0,17 — conservative balance sheet
Negative free cash flow of -70,72M
PEG of 0,27 suggests growth is underpriced
Capital efficient — spends only 7,08% of revenue on capex
Groei
Revenue Growth (5Y)
-30,57%
Revenue (1Y)-28,34%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-48,64%
ROIC-2,04%
Net Margin-70,41%
Op. Margin-3,63%
Veiligheid
Debt / Equity
0,17
Current Ratio6,60
Interest Coverage-0,25
Waardering
P/E Ratio
-6,53
Forward P/EN/A
P/B Ratio4,02
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -28,34% | Revenue Growth (3Y) | -19,82% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -30,57% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 185,74M | Net Income (TTM) | -130,77M |
| ROE | -48,64% | ROA | -16,97% |
| Gross Margin | 17,98% | Operating Margin | -3,63% |
| Net Margin | -70,41% | Free Cash Flow (TTM) | -70,72M |
| ROIC | -2,04% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,17 | Current Ratio | 6,60 |
| Interest Coverage | -0,25 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -6,53 | Forward P/E | N/A |
| P/B Ratio | 4,02 | P/S Ratio | 4,60 |
| PEG Ratio | 0,27 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | 16,02 |
| Forward P/S | 4,17 | Fwd Earnings Yield | N/A |
| FCF Yield | -8,28% | ||
| Market Cap | 854,47M | Enterprise Value | 673,16M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 185,74M | 259,19M | 288,95M | 883,00M | 799,24M |
| Net Income | -130,77M | -144,85M | -119,03M | 220,21M | 182,04M |
| EPS (Diluted) | -0,91 | -1,05 | -0,90 | 1,67 | 1,56 |
| Gross Profit | 33,39M | 108,31M | 140,20M | 714,04M | 658,68M |
| Operating Income | -6,74M | -235,62M | -31,65M | 574,22M | 554,65M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 770,58M | 1,01B | 1,49B | 2,28B | 1,92B |
| Total Liabilities | 397,87M | 431,04M | 697,57M | 1,38B | 1,37B |
| Shareholders' Equity | 212,38M | 325,29M | 416,75M | 545,22M | 315,50M |
| Total Debt | 35,58M | 376,69M | 610,97M | 585,26M | 575,22M |
| Cash & Equivalents | 216,89M | 322,40M | 574,96M | 632,14M | 551,27M |
| Current Assets | 296,25M | 429,15M | 699,91M | 847,90M | 740,04M |
| Current Liabilities | 44,92M | 56,97M | 87,47M | 110,14M | 93,78M |